Home > Search: Palgic D Tablets

• Search Results

Search Results Get Your Free Credit Report Right Now! Zip Code: Join our discussion forums! Providers join our directory! General Topics A-Z Conditions Treatments Medications Fitness Nutrition Anatomy Travel/Destinations Other Topics From the West From the East

Main Topic Area Palgic D Tablets All Topic Areas 1 - 10 of 333  more >> Carbinoxamine and Pseudoephedrine Tablets Coldec D Tablets Palgic D Tablets Rondec Tablets Carbinoxamine and Pseudoephedrine Extended-Release Tablets Coldec D Extended-Release Tablets Palgic-D Extended-Release Tablets Rondec-TR Tablets Carbinoxamine and Pseudoephedrine Oral Solution or Syrup Andehist Drops Articles 1 - 1 of 1 Statement on Generic Oxycodone Hydrochloride Extended Release Tablets The Food and Drug Administration today released the following statement on its approval of generic oxycodone hydrochloride extended-release tablets: Oxycodone hydrochloride extended-release products, such as OxyContin and its generic versions, are important options for the management of moderate-to-severe chronic pain, such as that associated with cancer and various other illnesses. FDA's approval of two generic oxycodone hydrochloride products should make this safe and effective medicine... U.S. Food and Drug Administration News 1 - 5 of 184  more >> Actavis Launches Alprazolam ER Tablets In The U.S. MedicalNewsToday - Thu, 15 Feb 2007 08:00 EST Tekturna(R) - The First New Type Of High Blood Pressure Medicine In More Than A Decade - Receives Its First Approval In The US MedicalNewsToday - Wed, 07 Mar 2007 08:00 EST Lipitor Significantly Reduced The Risk Of Serious Cardiovascular Events Compared With Simvastatin In An 80,000-Patient AnalysisManage MedicalNewsToday - Sat, 03 Mar 2007 08:00 EST Fish haters can get strong bones too Reuters - Fri, 23 Feb 2007 02:12 EST Drug Depot In A Tooth MedicalNewsToday - Sun, 18 Feb 2007 08:00 EST Clinical Trials 1 - 5 of 117  more >> Study of the Effectiveness and Tolerability of OROS Hydromorphone HCI SR(Slow-Release) Tablets and Immediate-Release Hydromorphone Tablets in Patients With Chronic Pain ClinicalTrials.gov Identifier: NCT00410943 - Active, not recruiting Pain PK, PD and Safety of Multiple Doses of V1512 Tablets in PD Patients Compared to Standard Levodopa/Carbidopa Oral Tablets ClinicalTrials.gov Identifier: NCT00491998 - Recruiting Parkinson's Disease Oxycodone-Naloxone Prolonged Release Tablets in Relieving Opioid-Related Constipation ClinicalTrials.gov Identifier: NCT00412100 - Active, not recruiting Pain An Open-Label Evaluation of the Dose Proportionality of OROS® Hydromorphone HCL Tablets 8mg, 16mg, 32mg, 64mg ClinicalTrials.gov Identifier: NCT00398957 - Active, not recruiting Analgesia Phase III Study to Assess the Long Term Efficacy, Carry-Over Effect and Safety of 300 IR Sublingual Immunotherapy Tablets ClinicalTrials.gov Identifier: NCT00418379 - Active, not recruiting Allergy

GoldBambooTM Your Integrative Health and Wellness Resource November 27, 2009

email this page   |    print this page   |    bookmark this page   |    feedback on this page Page Updated: January 17, 2009

Disclaimer: All material displayed on the GoldBamboo.com website is provided for educational purposes only. Consult a physician regarding the applicability of any information found on GoldBamboo.com to your symptoms or medical condition.